Latest News

Biotoxtech, South Korea to Deploy Comprehensive Suite of Preclinical Study Management and SEND Software Solutions from Instem

Instem Technology Selected to Streamline Preclinical Operations, Improve Productivity and Ensure SEND Compliance at South Korea’s Largest Preclinical R&D Facility

CONSHOHOCKEN, PA – Business Wire, June 3, 2020 - Instem, a leading provider of IT solutions to the global life sciences market, announced today that South Korean Contract Research Organization (CRO), Biotoxtech Co., Ltd. (Biotoxtech) has purchased a comprehensive package of preclinical data collection, analysis and regulatory submissions management solutions to automate and optimize study related processes at its R&D facility in South Korea’s North Chungcheong Province.  

Instem Reporting Strong Start to 2020 for Target Safety Assessment Services

April 29, 2020 - Instem Continues to Ramp up as Demand for Target Safety Assessment Service Reaches New Heights

INTOX, India Deploys Provantis Preclinical Software Solution

March 3, 2020 - Provantis Selected to Improve Study Turnaround Times and Further Increase Data Quality at Pune Facility

Instem Acquires Leadscope; Prominent Provider of In Silico Safety Assessment Solutions

November 15, 2019 - Instem’s Acquisition of Leadscope, Inc. is Another Step in its Mission to Help Clients Bring Life Enhancing Products to Market Faster

Instem to Exhibit and Present at the American College of Toxicology Meeting, Arizona

November 13, 2019 - Instem Continues Powerful Presentation Series Focusing on Their Use of Artificial and Augmented Intelligence Techniques to Improve Drug Development Processes

View all news




RAPS Convergence 2020

September 12 - 15, 2020

Virtual Conference

Visit Conference Site

SPS Annual Meeting

September 13 - 16, 2020

Virtual Conference

Visit Conference Site

View all events